Patents Assigned to SILVERGATE PHARMACAUTICALS, INC.
  • Enalapril compositions
    Patent number: 9968553
    Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: May 15, 2018
    Assignees: SILVERGATE PHARMACAUTICALS, INC., UNIVERSITY OF KANSAS
    Inventors: Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Segrave, Robert Mauro, Peter Colabuono